XON - Intrexon

XON valuation $2.89 billion

Stock Price

Change: ↓ -1.34 (-4.4592%)
Last Update: 2015-01-30T16:16:29-05:00
Shares Outstanding: 100,517,672
Industry: Biotechnology

Intrexon Corporation, founded in 1998, is a leader in synthetic biology focused on collaborating with companies in Health, Food, Energy, Environment and Consumer sectors to create biologically based products that improve quality of life and the health of the planet.

With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Working with key collaborators, Intrexon seeks to develop high value applications that can bring better medicines to more people, alleviate shortages of essential nutrients, develop renewable fuels and other resources, and protect the environment.

Stock Price Data

Open: 29.94 Previous Close: 30.05
High: 30.48 Low: 28.43
Bid: 28.00 Ask: 32.72

Bid Size: 300 Ask Size: 1000
Raw Bid Size: 3 Raw Ask Size: 10
Trade Volume: 9048 Share Volume: 1316765
Last Trade Date: 2015-01-30 Last Trade Time: 16:03:27-05:00
Vwap: 29.0983118 EPS: -0.37

Fundamental Data

PE ratio: PB ratio: 8.042
Beta: -2.099213

52 Week High: 40.49 52 Week Low: 13.13
52 Week High Vwap: 36.7193 52 Week Low Vwap: 14.3439
52 Week High Volume: 5193233 52 Week Low Volume: 167326
52 Week Avg Volume: 711103
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
GILD Gilead Sciences Inc. 104.83
IMGN ImmunoGen Inc. 7.63
CELG Celgene Corporation 119.16
ARNA Arena Pharmaceuticals Inc. 4.31
MNKD MannKind Corporation 6.35
AMGN Amgen Inc 152.26
NVAX Novavax Inc. 7.81
BIIB Biogen Idec Inc. 389.16
NPSP NPS Pharmaceuticals Inc. 45.86
ARIA ARIAD Pharmaceuticals Inc. 6.45